Key Takeaways Agilent reported Q1 EPS of $1.36, up Y/Y, while revenues rose 7% to $1.8 billion. Agilent saw revenue growth across LDG, ACG, and AMG, but segment margins declined Y/Y. Agilent guided Q2 revenues of $1.79-$1.82B and FY26 sales of $7.3-$7.5B. Agilent Technologies (A) reported first-quarter fiscal 2025 earnings of $1.36 per share, which missed the Zacks Consensus Estimate by 0.52%. The figure increased 3.8% year over year.Revenues of $1.8 billion surpassed the Zacks Consensus Estimate by 0.27%. ...

Life Sciences and Diagnostics Group (LDG): revenue grew 3%, below expectations, with management citing the weather disruption and continued softness in academia and government affecting cell analysis and genomics.Elinoff said first-quarter non-GAAP gross margin was 53.7%, down 100 basis points year over year, “primarily due to tariff headwinds.” Non-GAAP operating margin was 24.6%, down 50 basis points, which management attributed to higher tariff expenses and normalized performance-based pay. Non-GAAP EPS ...

For the quarter ended January 2026, Agilent Technologies (A) reported revenue of $1.8 billion, up 7% over the same period last year. EPS came in at $1.36, compared to $1.31 in the year-ago quarter.The reported revenue represents a surprise of -0.27% over the Zacks Consensus Estimate of $1.8 billion. With the consensus EPS estimate being $1.37, the EPS surprise was -0.52%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ex ...

Core Viewpoint - Agilent Technologies reported quarterly earnings of $1.36 per share, slightly missing the Zacks Consensus Estimate of $1.37 per share, but showing an increase from $1.31 per share a year ago, indicating a -0.52% earnings surprise [1] Financial Performance - The company posted revenues of $1.8 billion for the quarter ended January 2026, which was below the Zacks Consensus Estimate by 0.27%, compared to $1.68 billion in the same quarter last year [2] - Over the last four quarters, Agilent has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Agilent shares have declined approximately 8.6% since the beginning of the year, while the S&P 500 has gained 0.7% [3] - The current Zacks Rank for Agilent is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.40 on revenues of $1.76 billion, and for the current fiscal year, it is $5.93 on revenues of $7.34 billion [7] - The trend of earnings estimate revisions for Agilent was mixed ahead of the earnings release, which could change following the recent report [6] Industry Context - The Medical - Products industry, to which Agilent belongs, is currently ranked in the bottom 44% of over 250 Zacks industries, suggesting that the outlook for the industry can significantly impact stock performance [8]

Agilent Technologies (NYSE:A) Q1 2026 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsAdam Elinoff - Managing DirectorAngelica Riemann - President, Agilent CrossLab GroupBrandon Couillard - Managing DirectorCasey Woodring - VP of Equity ResearchMichael Ryskin - Managing DirectorPadraig McDonnell - President and CEOPatrick Donnelly - Managing Director in Equity ResearchPuneet Souda - Senior Managing Director, Life Science Tools and DiagnosticsSimon May - President of the Life Sciences and App ...

Agilent Technologies (NYSE:A) Q1 2026 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsAdam Elinoff - Managing DirectorAngelica Riemann - President, Agilent CrossLab GroupBrandon Couillard - Managing DirectorCasey Woodring - VP of Equity ResearchMichael Ryskin - Managing DirectorPadraig McDonnell - President and CEOPatrick Donnelly - Managing Director in Equity ResearchPuneet Souda - Senior Managing Director, Life Science Tools and DiagnosticsSimon May - President of the Life Sciences and App ...

Agilent Technologies (NYSE:A) Q1 2026 Earnings call February 25, 2026 04:30 PM ET Speaker9Ladies and gentlemen, thank you for joining us, and welcome to the Q1 2026 Agilent Technologies Inc. earnings conference call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please raise your hand. If you have dialed into today's call, please press star nine to raise your hand and star six to unmute. I will now hand the conference over to Tejas Savant, V ...

Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv Agilent reports in-line first quarter, says results hurt by US snowstorm February 25, 202610:24 PM UTCUpdated ago By Bageshri Banerjee Feb 25 (Reuters) - Life sciences firm Agilent Technologies (A.N), opens new tab on Wednesday reported first- quarter results that were largely in line with Wall Street estimates on stable demand for its medical tools and equipment used in lab research and diagn ...

FINANCIAL RESULTS OVERVIEW 1Q FY2026 February 25, 2026 Thank You for Your Attention Safe Harbor This presentation contains forward- looking statements (including, without limitation, information, and future guidance on the company's revenue, revenue growth, earnings per share, operating cash flow, capital expenditures, net interest and other/expense, impact of acquisitions and related financing, share repurchases, dividends, diluted share counts, and currency exchange rates) that involve risks and uncertain ...

Exhibit 99.1 Agilent Reports First-Quarter Fiscal Year 2026 Financial Results Delivers solid Q1 results, raises FY26 reported revenue outlook and increases non-GAAP EPS guidance while confirming core-revenue growth and margin expansion (3) (1) Life Sciences and Diagnostics Markets Group First-quarter fiscal year 2026 Fiscal year 2026 and second-quarter outlook SANTA CLARA, California, Feb. 25, 2026 — Agilent Technologies, Inc. (NYSE: A) today reported revenue of $1.80 billion for the first quarter ended Jan ...